Laser Photonics Raises $9.3 Million in Private Offering
CARLSBAD, Calif., Aug. 20 -- Laser Photonics Inc. has completed a private sale of restricted common stock. Company shares were offered at $4.50 per share to institutional and accredited investors through a placement agent, Pennsylvania Merchant Group. Laser Photonics plans to use the offering's net proceeds to fund marketing activities and additional clinical trials associated with the company's laser treatment for psoriasis. Proceeds will also go toward manufacturing, working capital, and general corporate purposes. Ray Hartman, Laser Photonics' president and CEO, commented, This financing will enable us to accelerate commercialization of our proprietary laser product for the treatment of psoriasis, a serious disease that has a major impact on patients' lives.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024